Cargando…

Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial Treatment

Background: In patients with differentiated thyroid cancer (DTC) and raising serum thyroglobulin (Tg) after total or near-total thyroidectomy and (131)I remnant ablation an empiric (131)I therapy may be considered. However, outcome data after empiric therapy in did not show a clear evidence of impro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klain, Michele, Pace, Leonardo, Zampella, Emilia, Mannarino, Teresa, Limone, Simona, Mazziotti, Emanuela, De Simini, Giovanni, Cuocolo, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423899/ https://www.ncbi.nlm.nih.gov/pubmed/30930852 http://dx.doi.org/10.3389/fendo.2019.00146

Ejemplares similares

Efficacy of Empirical Radioiodine Therapy in Patients with Differentiated Thyroid Cancer and Elevated Serum Thyroglobulin without Evidence of Structural Disease: A Propensity Score Analysis
por: Piscopo, Leandra, et al.
Publicado: (2023)

Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy
por: Salvatore, Barbara, et al.
Publicado: (2017)

Prognostic value of 12-month response to therapy in pediatric patients with differentiated thyroid cancer
por: Zampella, Emilia, et al.
Publicado: (2023)

Long-Term Prognostic Value of the Response to Therapy Assessed by Laboratory and Imaging Findings in Patients with Differentiated Thyroid Cancer
por: Klain, Michele, et al.
Publicado: (2021)

Lung Metastases From Papillary Thyroid Cancer With Persistently Negative Thyroglobulin and Elevated Thyroglobulin Antibody Levels During Radioactive Iodine Treatment and Follow-Up: Long-Term Outcomes and Prognostic Indicators
por: Qiu, Zhong-Ling, et al.
Publicado: (2020)

Second Primary Malignancies in Patients with Differentiated Thyroid Cancer after Radionuclide Therapy: A Retrospective Single-Centre Study
por: Piscopo, Leandra, et al.
Publicado: (2022)

Ablation rate after radioactive iodine therapy in patients with differentiated thyroid cancer at intermediate or high risk of recurrence: a systematic review and a meta-analysis
por: Klain, Michele, et al.
Publicado: (2021)

Combination of Stimulated Thyroglobulin and Antithyroglobulin Antibody Predicts the Efficacy and Prognosis of (131)I Therapy in Patients With Differentiated Thyroid Cancer Following Total Thyroidectomy: A Retrospective Study
por: Pan, Mengjiao, et al.
Publicado: (2022)

Iodine-131 and Thyroid Function
por: Sun, Wenjie
Publicado: (2014)

Nitric oxide, thyroglobulin, and calcitonin: unraveling the nature of thyroid nodules
por: Samardzic, Vladimir S., et al.
Publicado: (2023)

Utility of Stimulated Thyroglobulin in Reclassifying Low Risk Thyroid Cancer Patients’ Following Thyroidectomy and Radioactive Iodine Ablation: A 7-Year Prospective Trial
por: Jammah, Anwar A., et al.
Publicado: (2021)

The Role of Thyroglobulin in Preoperative and Postoperative Evaluation of Patients With Differentiated Thyroid Cancer
por: Li, Sha, et al.
Publicado: (2022)

Advances in Functional Imaging of Differentiated Thyroid Cancer
por: Klain, Michele, et al.
Publicado: (2021)

Urinary Exosomal Thyroglobulin in Thyroid Cancer Patients With Post-ablative Therapy: A New Biomarker in Thyroid Cancer
por: Huang, Tse-Ying, et al.
Publicado: (2020)

Thyroglobulin Value Predict Iodine-123 Imaging Result in Differentiated Thyroid Cancer Patients
por: Campennì, Alfredo, et al.
Publicado: (2023)

Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment – initial experience
por: Werner, R. A., et al.
Publicado: (2016)

The structure of natively iodinated bovine thyroglobulin
por: Kim, Kookjoo, et al.
Publicado: (2021)

Ultrasonography, Cytology, and Thyroglobulin Measurement Results of Cervical Nodal Metastasis in Patients With Unclear Papillary Thyroid Carcinoma
por: Lim, Jong Heon, et al.
Publicado: (2019)

Predictive Value of Thyroglobulin Changes for the Curative Effect of Radioiodine Therapy in Patients With Metastatic Differentiated Thyroid Carcinoma
por: Wang, Congcong, et al.
Publicado: (2021)

Comparing the efficacy of thyroglobulin and thyroglobulin/ thyroid-stimulating hormone ratio models in predicting a successful response to radioactive iodine therapy
por: Ju, Yanli, et al.
Publicado: (2023)

Thyroglobulin levels in COVID-19-positive patients: Correlations with thyroid function tests, inflammatory markers, and glucocorticoid use
por: Świątkowska-Stodulska, Renata, et al.
Publicado: (2023)

Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis
por: Wang, Chen, et al.
Publicado: (2017)

Combined bone scintigraphy and fluorocholine PET/computed tomography predicts response to radium-223 therapy in patients with prostate cancer
por: Klain, Michele, et al.
Publicado: (2021)

Preradioactive Iodine Thyroglobulin Levels as Predictors of Metastasis in Well-Differentiated Thyroid Carcinoma Patients
por: Darmawan, Budi, et al.
Publicado: (2022)

The Iodine Rush: Over- or Under-Iodination Risk in the Prophylactic Use of Iodine for Thyroid Blocking in the Event of a Nuclear Disaster
por: Calcaterra, Valeria, et al.
Publicado: (2022)

Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy
por: Hong, Chae Moon, et al.
Publicado: (2017)

Leukaemias and cancers following iodine-131 administration for thyroid cancer.
por: de Vathaire, F., et al.
Publicado: (1997)

Iodine-131 and Thyroid Function: Ostroumova et al. Respond
por: Ostroumova, Evgenia, et al.
Publicado: (2014)

Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis
por: Chang, Qungang, et al.
Publicado: (2022)

Radioactive Body Burden Measurements in (131)Iodine Therapy for Differentiated Thyroid Cancer: Effect of Recombinant Thyroid Stimulating Hormone in Whole Body (131)Iodine Clearance
por: Ravichandran, Ramamoorthy, et al.
Publicado: (2014)

Primary Cilia Mediate TSH-Regulated Thyroglobulin Endocytic Pathways
por: Lee, Junguee, et al.
Publicado: (2021)

Novel Therapeutics in Radioactive Iodine-Resistant Thyroid Cancer
por: Fullmer, Tanner, et al.
Publicado: (2021)

Clinical Analysis of Preoperative Anti-thyroglobulin Antibody in Papillary Thyroid Cancer Between 2011 and 2015 in Beijing, China: A Retrospective Study
por: Jia, Xiaomeng, et al.
Publicado: (2020)

Relationship of iodine excess with thyroid function in 6-year-old children living in an iodine-replete area
por: Lee, Yun Jeong, et al.
Publicado: (2023)

Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation
por: Schmidt, Angelica, et al.
Publicado: (2017)

Resveratrol Sensitizes Selectively Thyroid Cancer Cell to 131-Iodine Toxicity
por: Hosseinimehr, Seyed Jalal, et al.
Publicado: (2014)

The Value of Pre-Ablative I-131 Scan for Clinical Management in Patients With Differentiated Thyroid Carcinoma
por: van der Boom, Trynke, et al.
Publicado: (2021)

Radioactive iodine in low- to intermediate-risk papillary thyroid cancer
por: Zhao, Hengqiang, et al.
Publicado: (2022)

Relation between iodine nutrition and thyroid diseases in Qinghai, China
por: Fan, Xiaoxia, et al.
Publicado: (2023)

Emerging Role of Nuclear Medicine in Prostate Cancer: Current State and Future Perspectives
por: Volpe, Fabio, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iq81kg8atm5bc21v9fi1gbpt95